Ahmed Hamdy MD - 01 May 2025 Form 4 Insider Report for CURIS INC (CRIS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 May 2025, 16:26:25 UTC
Prior SEC filing
14 Aug 2024
Next SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Diantha Duvall, Attorney-in-fact

Key filing fact

Ahmed Hamdy MD filed Form 4 for CURIS INC (CRIS) on 05 May 2025.

Key facts

  • This page summarizes Ahmed Hamdy MD's Form 4 filing for CURIS INC (CRIS).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 05 May 2025, 16:26.

Change

  • Previous filing in this sequence was filed on 14 Aug 2024.
  • Current net transaction value: +$496,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001458506 Primary reporting owner

Hamdy Ahmed MD

Relationship
CMO
Address
128 SPRING STREET, BUILDING C - SUITE 500, LEXINGTON
Signature
/s/ Diantha Duvall, Attorney-in-fact
Signature date
05 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRIS transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
$496,000
Shares
+200,000
Change %
Price
$2.48
Shares after
200,000
Date
01 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Exercise price
$2.48
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This stock option vests over four years, with 25% of the original 200,000 shares underlying the award vesting on May 1, 2026 and an additional 6.25% of the original number of shares underlying the award vesting on each successive three-month period thereafter, subject to continued service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .